Centro de Pesquisas Oncologicas

Florianópolis, Santa Catarina 88034000

0 studies enrolling now · 4 studies all time

What they study most

Autologous Stem Cell Transplant, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Metastatic Breast Cancer, Multiple Myeloma, Myelodysplastic Syndrome, Relapsed or Refractory Systemic Light Chain Amyloidosis

Studies at this site

• ELACESTRANT in Women and Men With CDK4/6 Inhibitor-Naive Estrogen Receptor Positive, HER-2 Negative Metastatic Breast Cancer Study — Running, not enrolling
• Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML) — Completed
• Study of Dexamethasone Plus IXAZOMIB (MLN9708) or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis — Stopped early
• A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell Transplant — Completed